Joseph S. Zakrzewski - Insider Trading & Ownership

Entity
Individual
Location
509 Waterview Place, New Hope, PA
Summary
The estimated net worth of Joseph S. Zakrzewski is at least $1.41M dollars as of November 20, 2024. Joseph S. Zakrzewski is the Director of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $636K. Joseph S. Zakrzewski is the Director of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $534K. Joseph S. Zakrzewski is the Director of AMARIN CORP PLC\UK and owns shares of AMARIN CORP PLC\UK (AMRN) stock worth about $214K. Joseph S. Zakrzewski is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $23.2K.
All Insider Reports
All Insider Reports

Ownership of Joseph S. Zakrzewski

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CYT Cyteir Therapeutics, Inc. Director $636K Feb 6, 2024
ANTX AN2 Therapeutics, Inc. Director $534K -$1.89M -77.9% Nov 18, 2024
AMRN AMARIN CORP PLC\UK Director $214K Dec 14, 2021
SGMO SANGAMO THERAPEUTICS, INC Director $23.2K Feb 25, 2022
XLRN ACCELERON PHARMA INC Director Nov 19, 2021

Insider Transactions Reported by Joseph S. Zakrzewski:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.